Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Markets
Screener
News
About

Home

BLFS

(BLFS)

NCM – Real Time Price. Currency in USD

18.59

-1.06 (-5.39%)

At close: Mar 27, 2026, 4:00 PM EDT

18.59

0.00 (0.00%)

After-hours: Mar 27, 2026, 4:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

After Plunging 17.6% in 4 Weeks, Here's Why the Trend Might Reverse for BioLife Solutions (BLFS)

After Plunging 17.6% in 4 Weeks, Here's Why the Trend Might Reverse for BioLife Solutions (BLFS)

The heavy selling pressure might have exhausted for BioLife Solutions (BLFS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

BioLife Looks Strong For Fiscal Year 2026

BioLife Looks Strong For Fiscal Year 2026

BioLife Solutions has executed a successful turnaround by refocusing on core biopreservation media and vials, divesting non-core assets. BLFS expects 17–20% revenue growth in FY26, positive GAAP net income, and mid-60s gross margins, supported by dominant CGT market share. Strategic acquisitions like PanTHERA and partnerships such as QKine are set to drive ARPU expansion and next-gen product launches by late 2026.

Wall Street Analysts Believe BioLife Solutions (BLFS) Could Rally 35%: Here's is How to Trade

Wall Street Analysts Believe BioLife Solutions (BLFS) Could Rally 35%: Here's is How to Trade

The mean of analysts' price targets for BioLife Solutions (BLFS) points to a 35% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

BioLife Solutions, Inc. (BLFS) Q4 2025 Earnings Call Transcript

BioLife Solutions, Inc. (BLFS) Q4 2025 Earnings Call Transcript

BioLife Solutions, Inc. (BLFS) Q4 2025 Earnings Call Transcript

BioLife Solutions, Inc. (BLFS) Surpasses Q4 Earnings and Revenue Estimates

BioLife Solutions, Inc. (BLFS) Surpasses Q4 Earnings and Revenue Estimates

BioLife Solutions, Inc. (BLFS) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to a loss of $0.01 per share a year ago.

BioLife Solutions Reports Fourth Quarter and Full Year 2025 Financial Results from Continuing Operations

BioLife Solutions Reports Fourth Quarter and Full Year 2025 Financial Results from Continuing Operations

Fourth quarter 2025 revenue from continuing operations of $24.8 million, up 20% year-over-year; Full year 2025 revenue of $96.2 million, up 29% year-over-year GAAP gross margin of 63% and non-GAAP adjusted gross margin of 64% for the fourth quarter GAAP net income of $2.1 million or $0.04 per share and adjusted EBITDA of $6.9 million, or 28% of total revenue for the fourth quarter Expects 2026 revenue growth of $112.5 million to $115.0 million, up 17%-20% over 2025 Conference call begins at 4:30 p.m. Eastern time today BOTHELL, Wash.

BioLife Solutions to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update on February 26, 2026

BioLife Solutions to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update on February 26, 2026

BOTHELL, Wash., Feb. 17, 2026 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced the 2025 fourth quarter and full year financial results will be released on February 26, 2026.

Videos

No Data

There is no data to display